Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP
- 14 January 2002
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (2) , 169-174
- https://doi.org/10.1038/ni754
Abstract
Little is known about the processing of putative human autoantigens and why tolerance is established to some T cell epitopes but not others. Here we show that a principal human HLA-DR2–restricted epitope—amino acids 85–99 of myelin basic protein, MBP(85–99)—contains a processing site for the cysteine protease asparagine endopeptidase (AEP). Presentation of this epitope by human antigen-presenting cells is inversely proportional to the amount of cellular AEP activity: inhibition of AEP in living cells greatly enhances presentation of the MBP(85–99) epitope, whereas overexpression of AEP diminishes presentation. These results indicate that central tolerance to this encephalitogenic MBP epitope may not be established because destructive processing limits its display in the thymus. Consistent with this hypothesis, AEP is expressed abundantly in thymic antigen-presenting cells.Keywords
This publication has 41 references indexed in Scilit:
- Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteinsJournal of Molecular Biology, 2000
- CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULESAnnual Review of Immunology, 1997
- Three-dimensional Structure of Myelin Basic ProteinJournal of Biological Chemistry, 1997
- Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous SystemCell, 1996
- Isolation and characterization of the intracellular MHC class II compartmentNature, 1994
- Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.The Journal of Experimental Medicine, 1994
- Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.Journal of Clinical Investigation, 1993
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosisNature, 1990
- Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapyCell, 1989